Abstract
AbstractPlasmodium falciparum is a deadly protozoan parasite and the causative agent of malaria, which accounts for close to 200 million cases and 400,000 deaths every year. It has been identified to possess a tightly regulated gene expression profile that is integrally linked to its timely development during the intraerythrocytic stage. Epigenetic modifiers of the histone acetylation code have been identified as key regulators of the parasite’s transcriptome. In this study, we characterize the solitary class I histone deacetylase PfHDAC1 and demonstrate that phosphorylation is required for its catalytic activity. PfHDAC1 binds to and regulates parasite genes responsible for housekeeping and stress-responsive functions. We show that PfHDAC1 activity in parasites is crucial for normal intraerythrocytic development and that its cellular abundance is correlated with parasitemia progression. We further show that PfHDAC1 has differential abundance and genomic occupancy in artemisinin drug-resistant vs sensitive parasites and that inhibition of its deacetylase activity can modulate the sensitivity of parasites to the drug. We also identify that artemisinin exposure can interfere with PfHDAC1 phosphorylation and its genomic occupancy. Collectively, our results demonstrate PfHDAC1 to be an important regulator of basic biological functions in parasites while also deterministic of responses to environmental stresses such as antimalarial drugs.
Publisher
Cold Spring Harbor Laboratory
Reference57 articles.
1. WHO (2020) World malaria report 2020: 20 years of global progress and challenges in World malaria report 2020: 20 years of global progress and challenges.
2. An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum;The American Journal of Tropical Medicine Hygiene,2006
3. Antimalarial drugs: modes of action and mechanisms of parasite resistance;Future Microbiology,2010
4. Antimalarial Drug Resistance: A Threat to Malaria Elimination
5. WHO (2016) Artemisinin and artemisinin-based combination therapy resistance: status report in, World Health Organization,
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献